A.C., N., C.D., M., S., R., H., A., A.Y., S., M.K., S., . . . PHARMACOLOGY. (2018). Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS).
استشهاد بنمط شيكاغوA.C., Nirvanappa, et al. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS), 2018.
MLA استشهادA.C., Nirvanappa, et al. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS), 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.